tiprankstipranks
Trending News
More News >
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market

Alto Neuroscience, Inc. (ANRO) Stock Statistics & Valuation Metrics

Compare
459 Followers

Total Valuation

Alto Neuroscience, Inc. has a market cap or net worth of $71.47M. The enterprise value is $563.15M.
Market Cap$71.47M
Enterprise Value$563.15M

Share Statistics

Alto Neuroscience, Inc. has 27,072,128 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,072,128
Owned by Insiders8.38%
Owned by Institutions37.18%

Financial Efficiency

Alto Neuroscience, Inc.’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -40.95%.
Return on Equity (ROE)-0.41
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-40.95%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee0.00
Profits Per Employee-808.30K
Employee Count76
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Alto Neuroscience, Inc. is -1.69. Alto Neuroscience, Inc.’s PEG ratio is -0.10.
PE Ratio-1.69
PS Ratio0.00
PB Ratio-13.78
Price to Fair Value0.69
Price to FCF-25.06
Price to Operating Cash Flow-25.96
PEG Ratio-0.10

Income Statement

In the last 12 months, Alto Neuroscience, Inc. had revenue of 0.00 and earned -61.43M in profits. Earnings per share was -2.50.
Revenue0.00
Gross Profit0.00
Operating Income-68.61M
Pretax Income-61.43M
Net Income-61.43M
EBITDA-68.61M
Earnings Per Share (EPS)-2.50

Cash Flow

In the last 12 months, operating cash flow was -53.00M and capital expenditures -1.88M, giving a free cash flow of -54.87M billion.
Operating Cash Flow-53.00M
Free Cash Flow-54.87M
Free Cash Flow per Share-2.03

Dividends & Yields

Alto Neuroscience, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.76
52-Week Price Change-79.20%
50-Day Moving Average2.39
200-Day Moving Average5.33
Relative Strength Index (RSI)47.98
Average Volume (3m)219.28K

Important Dates

Alto Neuroscience, Inc. upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend Date

Financial Position

Alto Neuroscience, Inc. as a current ratio of 16.92, with Debt / Equity ratio of -213.78%
Current Ratio16.92
Quick Ratio16.92
Debt to Market Cap0.11
Net Debt to EBITDA2.20
Interest Coverage Ratio49.90

Taxes

In the past 12 months, Alto Neuroscience, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Alto Neuroscience, Inc. EV to EBITDA ratio is 0.69, with an EV/FCF ratio of 0.95.
EV to Sales0.00
EV to EBITDA0.69
EV to Free Cash Flow0.95
EV to Operating Cash Flow1.00

Balance Sheet

Alto Neuroscience, Inc. has $160.75M in cash and marketable securities with $4.41M in debt, giving a net cash position of -$156.34M billion.
Cash & Marketable Securities$160.75M
Total Debt$4.41M
Net Cash-$156.34M
Net Cash Per Share-$5.78
Tangible Book Value Per Share$6.16

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Alto Neuroscience, Inc. is $11.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$11.75
Price Target Upside345.08% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score5
AI Score42
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis